Nearly all emergency physicians are seeing an increase in violence, and they say it’s taking a toll on doctors, nurses and patient care. https://t.co/ccSmSsWwPd via @ChiefHealthExec@RonSouthwick1
In recognizing the value-based aspects that drive patient outcomes within oncology, effective cancer care has been redefined in New Jersey to incorporate cost and health equity at the forefront of innovation https://t.co/ukFZ19BRjW via @AJMC_Journal
Panelists at DIA #Biosimilars22 addressed how biosimilars can help address health care disparities and why patient notification for switching to biosimilars must be handled with caution. https://t.co/M9CkYCry3m
Hospitals have faced increased pressure to reduce their environmental impact, and a new congressional report offers more perspective on what some health systems are doing. https://t.co/wBXSPNWHR9 via @ChiefHealthExec@RonSouthwick1
World Health Organization said there is a lack of evidence of clinical effectiveness of the monoclonal antibodies Xevudy and Regen-Cov against the COVID-19 variants that are currently circulating. https://t.co/IY0ZfULJFI via @denise_myshko
The FDA issued an alert to users related to a potential cybersecurity risk for Medtronic MiniMed 600 Series Insulin Pump Systems. The risk could allow unauthorized users to change insulin levels https://t.co/FcYjXJSg9U via @Drug_Topics
Part 3 of a @BiosimCenter series dives into how providers, administrators, nurses, and pharmacists can prepare for adalimumab biosimilars and what role they can play in patient acceptance and use of biosimilars https://t.co/F0mSms3OYy
Reaching the goals of the Cancer Moonshot 2.0 will require going beyond the traditional measures of success and truly learning from patients and caregivers living with cancer, explained the Moonshot coordinator at the #NCCNPolicy Summit
https://t.co/ydZR2OODPz via @AJMC_Journal